河南利欣制药股份有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
65
NMPA:65
Drug Approvals
Metronidazole and Glucose Injection
- Product Name
- 甲硝唑葡萄糖注射液
- Approval Number
- 国药准字H41022795
- Approval Date
- Feb 5, 2024
NMPA
Houttuyniae herba Injection
- Product Name
- 鱼腥草注射液
- Approval Number
- 国药准字Z41021628
- Approval Date
- Feb 5, 2024
NMPA
Ligustrazine Hydrochloride Injection
- Product Name
- 盐酸川芎嗪注射液
- Approval Number
- 国药准字H20058128
- Approval Date
- Feb 5, 2024
NMPA
Glucose and Sodium Chloride Injection
- Product Name
- 葡萄糖氯化钠注射液
- Approval Number
- 国药准字H20113225
- Approval Date
- Feb 5, 2024
NMPA
Sodium Chloride Injection
- Product Name
- 氯化钠注射液
- Approval Number
- 国药准字H20123208
- Approval Date
- Jan 23, 2024
NMPA
Compound Sodium Chloride Injection
- Product Name
- 复方氯化钠注射液
- Approval Number
- 国药准字H20204045
- Approval Date
- Oct 12, 2020
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- Next
Clinical Trials
No trials found
News
No news found